1. Home
  2. MAIA vs STCN Comparison

MAIA vs STCN Comparison

Compare MAIA & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • STCN
  • Stock Information
  • Founded
  • MAIA 2018
  • STCN 1986
  • Country
  • MAIA United States
  • STCN United States
  • Employees
  • MAIA N/A
  • STCN N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • STCN Advertising
  • Sector
  • MAIA Health Care
  • STCN Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • STCN Nasdaq
  • Market Cap
  • MAIA 62.4M
  • STCN 63.4M
  • IPO Year
  • MAIA 2022
  • STCN 1994
  • Fundamental
  • Price
  • MAIA $2.82
  • STCN $10.40
  • Analyst Decision
  • MAIA
  • STCN
  • Analyst Count
  • MAIA 0
  • STCN 0
  • Target Price
  • MAIA N/A
  • STCN N/A
  • AVG Volume (30 Days)
  • MAIA 60.0K
  • STCN 11.9K
  • Earning Date
  • MAIA 11-05-2024
  • STCN 12-12-2024
  • Dividend Yield
  • MAIA N/A
  • STCN N/A
  • EPS Growth
  • MAIA N/A
  • STCN 203.29
  • EPS
  • MAIA N/A
  • STCN 3.17
  • Revenue
  • MAIA N/A
  • STCN $169,044,000.00
  • Revenue This Year
  • MAIA N/A
  • STCN N/A
  • Revenue Next Year
  • MAIA N/A
  • STCN N/A
  • P/E Ratio
  • MAIA N/A
  • STCN $3.19
  • Revenue Growth
  • MAIA N/A
  • STCN N/A
  • 52 Week Low
  • MAIA $0.82
  • STCN $7.36
  • 52 Week High
  • MAIA $5.99
  • STCN $13.00
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 50.98
  • STCN 57.19
  • Support Level
  • MAIA $2.36
  • STCN $9.90
  • Resistance Level
  • MAIA $2.72
  • STCN $10.29
  • Average True Range (ATR)
  • MAIA 0.22
  • STCN 0.39
  • MACD
  • MAIA 0.02
  • STCN 0.11
  • Stochastic Oscillator
  • MAIA 72.28
  • STCN 100.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

Share on Social Networks: